A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

This study is looking at a medicine called guselkumab, which is used to treat inflammatory bowel disease (IBD). IBD includes conditions like Crohn's disease and ulcerative colitis, which cause ongoing inflammation in the digestive system. While we know guselkumab can help, this study wants to see how well it works and how it affects people in real-life situations, outside of typical research trials. It’s like watching how a car performs on everyday roads, not just on a test track.

The main goal is to understand who might benefit most from guselkumab. Researchers will look at how effective the medicine is for all participants and for different groups, for example, based on their age or how severe their condition is. They also want to understand the bigger picture of how the treatment impacts people's lives.

This includes asking about things like how tired they feel, their overall quality of life, how their condition affects their relationships and sex life, and their ability to work or do daily activities. They’ll also ask how satisfied people are with their treatment. This kind of information is really important because it helps doctors and patients make better decisions about treatment, focusing on what matters most for daily well-being.